Sales Guidance Raised $50M+

Discussion in 'Valeant Pharmaceuticals' started by anonymous, May 9, 2017 at 5:45 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    even though we sold 2 assets
     

  2. anonymous

    anonymous Guest

    The increase is related to some of the newly approved products coming on-line later this year that we hope to offset the lost sales from LOE and sold assets. Basically, it's going to be flat since 50m increase on 9b is white noise.
     
  3. anonymous

    anonymous Guest

    Pipeline is junk. Let me know how Broda/saliq does next few months. Value based contracting requires 3 to 6 months of pure PAP which means no bottom line profit until payers tier it. Unless pbms block or step edit others that will be negative margin until 2H2018 f any opex is dedicated launch. Best of luck
     
  4. anonymous

    anonymous Guest


    that made no fucking sense.

    Siliq will be the cheapest drug on the market by at over thousand dollars why wouldnt payers and PBMs want it.

    Now if you dont mind please suck on this dick
     
  5. anonymous

    anonymous Guest

    You know very little about the market. It doesn't just happen over night. Unless they caught the contracting review period, which happens annually, they will be filling at risk and subsidizing patients until each plan makes adjustments. The payers will take their sweet time while drug is given out for free until enough patients are on it. Not to mention safety issues with suicide and I believe it got stuck with a blackbox warning or narrowly avoided it.

    valeant also did not hire a biologic field force which is generally a must for companies who understand how important it is to navigate all the payer hurdles in that market. Take a look at the oral oncology market smart guy..

    First to market is still generally king, especially in derm where illnesses not as serious as others. Go back to school or get a real job in the industry until you learn something.
     
  6. anonymous

    anonymous Guest

    Cheap doesn't mean effective. And the black box warning is a huge red flag.
     
  7. anonymous

    anonymous Guest

    There's a reason that they priced it below their competitors, since it's newer to market and the possible side effects. Most doctors will be cautious about it, since they will be sued, if patients start killing themselves off despite the warnings.

    By the way, the whole world has been searching for your dick, and since it's microscopically small, it'll be hard to suck on it. Additionally, nothing makes sense to you because you're a moron. Nuff said.
     
  8. anonymous

    anonymous Guest

    Corrected for accuracy
     
  9. anonymous

    anonymous Guest

    ROTFLMAO